Old Mission Capital’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Old Mission Capital’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,656	Closed	-$413K	–	985
2022 Q2	$413K	Sell	7,656 -8,447	-52%	-$473K	0.01%	842
2022 Q1	$776K	Buy	16,103 +9,474	+143%	+$484K	0.02%	568
2021 Q4	$266K	Buy	+6,629	New	+$260K	0.01%	780
2021 Q3	–	Sell	-15,107	Closed	-$556K	–	992
2021 Q2	$556K	Sell	15,107 -7,704	-34%	-$327K	0.02%	614
2021 Q1	$1.03M	Buy	+22,811	New	+$959K	0.06%	357

Other funds holding BIS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Old Mission Capital's BIS Position: Q3 2022 in Review

Old Mission Capital sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2022, closing a stake of 7,656 shares — an estimated $413K sold.

Old Mission Capital first reported a position in BIS in Q1 2021 and held it in 5 quarters. The position peaked at $1.03M in Q1 2021. 7 funds tracked by Wall St. Rank hold BIS as of Q3 2022.

Old Mission Capital reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2022 after selling out during the quarter.
Old Mission Capital sold 7,656 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2022, an estimated $413K.
Old Mission Capital first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q1 2021 and held it in 5 quarters.
Old Mission Capital's ProShares UltraShort NASDAQ Biotechnology position peaked at $1.03M in Q1 2021.
7 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2022.

Based on Old Mission Capital's 13F filing for Q3 2022, filed 14 Nov 2022.